The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $158.84

Today's change+4.58 +2.97%
Updated June 22 2:29 PM EDT. Delayed by at least 15 minutes.
 

Jazz Pharmaceuticals PLC

Nasdaq: JAZZ
Last

(U.S.) $158.84

Today's change+4.58 +2.97%
Updated June 22 2:29 PM EDT. Delayed by at least 15 minutes.

Jazz Pharmaceuticals PLC Hits New 20-day High

Jazz Pharmaceuticals PLC is up sharply today, rallying (U.S.)$4.58 or 2.97% to (U.S.)$158.84 and setting a new 20-day high. Over the last five days, shares have gained 5.91% and are currently 3.00% off of the 52-week high. Shares have underperformed the S&P 500 by 5.87% during the last year.

Key company metrics

  • Open(U.S.) $154.89
  • Previous close(U.S.) $154.26
  • High(U.S.) $159.42
  • Low(U.S.) $154.02
  • Bid / Ask(U.S.) $158.66 / (U.S.) $159.00
  • YTD % change+45.68%
  • Volume567,359
  • Average volume (10-day)547,110
  • Average volume (1-month)489,322
  • Average volume (3-month)528,571
  • 52-week range(U.S.) $95.80 to (U.S.) $163.75
  • Beta1.13
  • Trailing P/E23.89×
  • P/E 1 year forward14.03×
  • Forward PEG0.79×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $6.65
Updated June 22 2:29 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.69%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue376397374381
Total other revenue--------
Total revenue376397374381
Gross profit351363350357
Total cost of revenue25342424
Total operating expense240231239212
Selling / general / administrative144126124123
Research & development45446339
Depreciation / amortization26262627
Interest expense (income), net operating--------
Unusual expense (income)--210
Other operating expenses, total--------
Operating income136166136169
Interest income (expense), net non-operating-19-19-18-12
Gain (loss) on sale of assets--------
Other--------
Income before tax116151116157
Income after tax8712487111
Income tax, total29272945
Net income8712487111
Total adjustments to net income--------
Net income before extra. items8712487111
Minority interest--000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items8712487111
Inc. avail. to common incl. extra. items8712487111
Diluted net income8712487111
Dilution adjustment------0
Diluted weighted average shares61626262
Diluted EPS excluding extraordinary itemsvalue per share1.412.021.411.80
Dividends per sharevalue per share0.00--0.000.00
Diluted normalized EPSvalue per share1.412.041.421.80